📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data. (2016)

First Author: Wendling T

Attributed to: Rare disease use of clinical trial simulation for the chioce and optimization of study designs/Priomedchild Call/ER funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00280-016-2994-x

PubMed Identifier: 26940939

Publication URI: http://europepmc.org/abstract/MED/26940939

Type: Journal Article/Review

Volume: 77

Parent Publication: Cancer chemotherapy and pharmacology

Issue: 5

ISSN: 0344-5704